Office Lease THE TOWERS @ SHORES CENTER REDWOOD CITY, CALIFORNIA Between CA- TOWERS AT SHORES CENTER LIMITED PARTNERSHIP, a Delaware limited partnership as Landlord, and BIOGENERICS, INC., a Delaware corporation as TenantOffice Lease • August 4th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • California
This Office Lease (this “Lease”), dated as of the date set forth in Section 1.1, is made by and between CA-TOWERS AT SHORES CENTER LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and BIOGENERICS, INC., a Delaware corporation (“Tenant”). The following exhibits are incorporated herein and made a part hereof: Exhibit A (Outline of Premises); Exhibit B (Work Letter); Exhibit C (Form of Confirmation Letter); Exhibit D (Rules and Regulations); Exhibit E (Judicial Reference); and Exhibit F (Additional Provisions).
COHERUS BIOSCIENCES, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • August 4th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Delaware
This Third Amended and Restated Investor Rights Agreement (the “Agreement”) is made as of May 9, 2014, among Coherus BioSciences, Inc., a Delaware corporation (the “Company”), and the stockholders listed on Exhibit A hereto (individually an “Investor” and collectively the “Investors”).
June 23, 2014 Doug Farrar [Redacted] Dear Doug:Coherus BioSciences, Inc. • August 4th, 2014 • Biological products, (no disgnostic substances)
This letter (the “Agreement”) confirms the details of the separation package offered to you by Coherus Biosciences, Inc. (the “Company”). Kindly sign where indicated below, and return this letter to me no earlier than June 30, 2014 and no later than July 14, 2014 to signify your agreement to the stated terms. This Agreement shall be effective as of the eighth (8th) day following your execution of it without revocation (the “Effective Date”).
FIRST AMENDMENT TO LEASELease • August 4th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances)
Provided Tenant has complied with all the terms and conditions of the lease and is still in occupancy of the Premises, Tenant shall have an On Going Right of First Refusal to lease any space immediately adjacent to the Premises at the same terms and conditions of any bonafide written offer from a third party. Tenant shall have five (5) business days to notify Landlord of its intention to lease the space. If Tenant elects not to Lease such space Landlord may offer such space to third parties upon the same terms and conditions as contained in Landlord’s prior written notification to Tenant.
AGREEMENT AND PLAN OF MERGER BY AND AMONG COHERUS BIOSCIENCES, INC., COHERUS INTERMEDIATE CORP., COHERUS ACQUISITION CORP., INTEKRIN THERAPEUTICS INC., AND FORTIS ADVISORS LLC Dated as of January 8, 2014Agreement and Plan of Merger • August 4th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of January 8, 2014, by and among COHERUS BIOSCIENCES, INC., a Delaware corporation (“Parent”), COHERUS INTERMEDIATE CORP., a Delaware corporation (“Acquisition HoldCo”), COHERUS ACQUISITION CORP., a Delaware corporation (“Acquisition Corp.”), INTEKRIN THERAPEUTICS INC., a Delaware corporation (the “Company”) and FORTIS ADVISORS LLC, a Delaware limited liability company, solely in its capacity as the Stockholders’ Representative. Certain capitalized terms used in this Agreement have the meanings ascribed to them in Article X.
SECOND AMENDMENTCoherus BioSciences, Inc. • August 4th, 2014 • Biological products, (no disgnostic substances)
THIS SECOND AMENDMENT (this “Second Amendment”) is made and entered into as of September 11, 2013, by and between CA-TOWERS AT SHORES CENTER LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and COHERUS BIOSCIENCES, INC., a Delaware corporation (“Tenant”).
